Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Analgesics, Opioid × Clear all

Phase

Status

Sponsor Class

OTHER 12 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 841 Carboplatin 782 Paclitaxel 771 Gemcitabine 645 Cisplatin 622 Docetaxel 588 Bevacizumab 500 Pemetrexed 406 Cyclophosphamide 395 Nivolumab 390 Capecitabine 375 Fluorouracil 328 Dexamethasone 322 Rituximab 311 Oxaliplatin 280 Injections 279 atezolizumab 249 Trastuzumab 241 Cetuximab 227 Leucovorin 225 Irinotecan 214 Prednisone 211 130-nm albumin-bound paclitaxel 210 Doxorubicin 209 Ipilimumab 185 Lenalidomide 182 Fulvestrant 177 fludarabine 176 durvalumab 168 venetoclax 164

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡